Endogenous VEGF signaling acts as a guardian of human primed pluripotency
Authors:
Open Access
- 12 March 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17
Abstract
The maintenance of human embryonic stem cell (hESC) self-renewal and pluripotency is governed by distinct signaling pathways, yet endogenous pluripotency-supporting pathways remain understudied despite extensive exogenous signaling research. Here, we identify a previously unrecognized role of endogenous VEGF signaling in sustaining primed hESC pluripotency. VEGF signaling is robustly activated in primed hESCs, quiescent in naïve cells, and inactivated upon differentiation. Strikingly, targeted VEGFR inhibition (pharmacological, soluble decoy receptors [sFLT1/sKDR], or CRISPR-mediated VEGFR1/2 knockout) in primed hESCs disrupts self-renewal and induces trophoblast-like differentiation. Mechanistically, VEGFR inhibition activates the BMP pathway and down-regulates NANOG, which directly binds and represses select BMP components and trophoblast lineage-specific genes. Functionally, BMP inhibition partially and NANOG overexpression substantially rescue the phenotype induced by VEGF signaling ablation. Collectively, our work uncovers a pivotal VEGF-dependent network maintaining primed pluripotency, providing valuable insights into integrated pluripotency and lineage regulation by signaling cascades and transcription factors.Keywords
This publication has 63 references indexed in Scilit:
- Induction of Human Naïve Pluripotency Using 5i/L/A Medium2021
- The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data TypesGenomics, Proteomics & Bioinformatics, 2021
- Discovering the role of VEGF signaling pathway in mesendodermal induction of human embryonic stem cellsBiochemical and Biophysical Research Communications, 2021
- VEGF in Signaling and Disease: Beyond Discovery and DevelopmentCell, 2019
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity GenesCell, 2013
- TGFβ and SMADs Talk to NANOG in Human Embryonic Stem CellsCell Stem Cell, 2008
- NANOG Is a Direct Target of TGFβ/Activin-Mediated SMAD Signaling in Human ESCsCell Stem Cell, 2008
- Stem Cells and Early Lineage DevelopmentCell, 2008
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005
- A Controlled Prospective Trial of Adjuvant Razoxane in Resectable Colorectal Cancer1981